Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Incyte Corporation INCY

Healthcare  —  Biotechnology
123.20 (1.62) (1.30%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Incyte Corporation (INCY) P/E ratio

As of 28 September 2026, Incyte Corporation (INCY) trades at a P/E ratio of 15.4×. Over the past ten years it has ranged from 0.0× (March 2021) to 5,423× (December 2015); the current reading is higher than 36% of that period. That is above the Biotechnology industry median of 7.7× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 15.0× (93.28%)
FY2024 223× 808.93%
FY2023 24.5× (52.55%)
FY2022 51.7× 201.91%
FY2021 17.1× —
FY2020 0.0× —
FY2019 42.0× (65.67%)
FY2018 122× —
FY2017 0.0× —
FY2016 183× (96.63%)

Quarterly

Period P/E ratio Change
Jun 2026 13.9× 8.15%
Mar 2026 12.9× (13.85%)
Dec 2025 15.0× 7.99%
Sep 2025 13.9× (8.43%)
42 more quarters

Against its own ten years

Low 0.0× High 5,423×
Ten-year median 19.6×
Current reading's percentile 36

P/E ratio against peers

Company P/E ratio
BNTX BioNTech SE Sponsored ADR compare n/m
ROIV Roivant Sciences Ltd. compare n/m
INSM Insmed, Inc. compare n/m
INCY Incyte Corporation 15.4×
JAZZ Jazz Pharmaceuticals PLC compare 15.6×
GMAB Genmab A/S Sponsored ADR compare 27.9×
RPRX Royalty Pharma PLC compare 40.3×
ALNY Alnylam Pharmaceuticals, Inc. compare 43.5×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 62.2×
Biotechnology industry median 7.7×
Healthcare sector median 22.7×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on INCY